Epilepsy deaths: level of risk in medication brand switch unclear, study says

17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...

Read more →

U.S. targets drug pricing, no-poach deals for anti-trust action in 2020

15 January 2020 - Justice Department antitrust chief also promises decision on music licensing, criticizes states’ lawsuit against T-Mobile and Sprint. ...

Read more →

Atomoxetine – further delay in change of funded brand and open access

10 January 2020 - PHARMAC is advising all interested parties that there is a further delay in the listing of ...

Read more →

California eyes selling its own brand of generic prescription drugs to battle high costs

9 January 2020 - California would become the first state to sell its own brand of generic prescription drugs in ...

Read more →

PHARMAC epilepsy drug process questions

10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...

Read more →

Generic makers will appeal ruling that allows California to proceed with law banning pay-to-delay deals

3 January 2020 - A federal judge dealt the pharmaceutical industry a setback by declining to block a new California ...

Read more →

'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem

2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...

Read more →

FDA approves first generics of Eliquis

23 December 2019 - The U.S. FDA has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce ...

Read more →

Request for information on lamotrigine brand change

 9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...

Read more →

PHARMAC brand switch: man driving through Waterview Tunnel blacked out

18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...

Read more →

Calls for answers about PHARMAC delay after epilepsy deaths

17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...

Read more →

Lamotrigine NPPA change

17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...

Read more →

FDA issues new analysis linking greater generic competition and lower generic drug prices

13 December 2019 - Greater competition among generic drug makers is associated with lower generic drug prices, according to a new ...

Read more →

Endo launches generic version of Afinitor (everolimus) tablets in the United States

10 December 2019 - Endo International today announced that one of its operating companies, Par Pharmaceutical, has received approval for and ...

Read more →

FDA approves first generics of Gilenya

5 December 2019 - The U.S. FDA has approved three applications for first generics of Gilenya (fingolimod) capsules for the ...

Read more →